The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations.

The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy ... “Our goal is to ensure that Lilly antibody treatments are available to patients who need them, no matter ...

An international trial is testing remternetug in young adults at genetic risk for early-onset Alzheimer’s. The study aims to ...

It’s been a rough month for several clinical amyotrophic lateral sclerosis (ALS) candidates, but that’s not stopping Eli Lilly from pursuing new drugs of its own for the devastating ...

Eli Lilly's operational performance is strong ... And finally, Emgality, which serves as a humanized monoclonal antibody for those who suffer from migraines, saw a rise in revenue from $168.5 ...

This quarter, there’s plenty to watch out for, including an interim Phase 3 analysis from Ultragenyx on its osteogenesis imperfecta antibody drug setrusumab, and another from Praxis Precision ...